Potential of immobilized artificial membranes for predicting drug penetration across the blood-brain barrier

Pharmaceutical Research

Volumn 15, Issue 8, 1998, Pages 1270-1274

  Reichel, Andreas ^a   Begley, David J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Blood brain barrier (BBB); Drug transport; HPLC; Immobilized artificial membrane (IAM); Prediction of brain uptake

Indexed keywords

ADRENALIN; ALDOSTERONE; AMPHETAMINE; BIOGENIC AMINE; CORTICOSTERONE; DOPAMINE; ESTRADIOL; HYDROCORTISONE; NORADRENALIN; PROGESTERONE; SEROTONIN; STEROID; TESTOSTERONE; TRYPTOPHOL;

ARTICLE; ARTIFICIAL MEMBRANE; BLOOD BRAIN BARRIER; DRUG DETERMINATION; DRUG PENETRATION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; PRIORITY JOURNAL;

BIOGENIC AMINES; BLOOD-BRAIN BARRIER; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; MEMBRANES, ARTIFICIAL;

EID: 0031709543     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011904311149     Document Type: Article

References (26)

1. M. W. B. Bradbury. The blood-brain barrier. Exp. Physiol. 78:453-472 (1993).
2. V. A. Levin. Relation of octanol/water partition and molecular weight to rat brain capillary permeability J. Med. Chem. 23:682-684 (1980).
3. N. J. Abbott and I. A. Romero. Transporting therapeutics across the blood-brain barrier. Mol. Medicine Today 2:106-113 (1996).
4. R. A. Conradi, P. S. Burton, and R. T. Borchardt. Physico-chemical and biological factors that influence a drug's cellular permeability by passive diffusion. In V. Pliska, B. Testa and H. van de Waterbeemd (eds.), Lipophilicity in Drug Action and Toxicology, VCH, Weinheim, 1996, pp. 233-251.
5. C. A. Bailey, P. Bryla, and A. W. Malick. The use of the intestinal epithelial cell culture model. Caco-2, in pharmaceutical development. Adv. Drug Deliv. Rev. 22:85-100 (1996).
6. W. M. Pardridge. Transport of small molecules through the blood-brain barrier: biology and methodology. Adv. Drug Deliv. Rev. 15:5-36 (1995).
7. R. C. Young, R. C. Mitchell, T. H. Brown, C. R. Ganellin, R. Griffith, M. Jones, K. K. Rana, D. Saunders, I. R. Smith, N. E. Sore, and T. J. Wilks. Development of a new physicochemical model for brain penetration and its application to the design of centrally acting H2 receptor histamine antagonists. J. Med. Chem. 31, 656-671 (1988).
8. J. G. Dorsey and M. G. Khaledi. Hydrophobicity estimations by reversed-phase liquid chromatography. Implications for biological partitioning processes. J. Chrom. 656:485-499 (1993).
9. S. Ong, H. Lui, X. Qiu, G. Bhat, and C. Pidgeon. Membrane partition coefficients chromatographically measured using immobilized artificial membrane surfaces. Anal. Chem. 67:755-762 (1995).
10. M. H. Abraham and H. S. Chadha. Applications of a solvation equation to drug transport properties. In V. Pliska, B. Testa and H. van de Waterbeemd (eds.), Lipophilicity in Drug Action and Toxicology, VCH, Weinheim, 1996, pp. 311-337.
11. A. Seelig, R. Gottschlich, and R. M. Devant. A method to determine the ability of drugs to diffuse through the blood-brain barrier. Proc. Natl. Acad. Sci USA 91:68-72 (1994).
12. S. C. Basak, B. D. Gute, and L. R. Drewes. Predicting blood-brain transport of drugs: a computational approach. Pharm. Res. 13:775-778 (1996).
13. F. M. Alvarez, C. B. Bottom, P. Chikhale, and C. Pidgeon. Immobilized artificial membrane chromatography. Prediction of drug transport across biological barriers. In T. Ngo (ed.), Molecular Interactions in Bioseparation. Plenum Press, New York, 1993, pp. 151-167.
14. C. Pidgeon, C. Marcus, and F. Alvarez. Immobilized artificial membrane chromatography: surface chemistry and applications. In J. W. Kelly and T. O. Baldwin (eds.), Applications of Enzyme Biotechnology, Plenum Press, New York, 1991, pp. 201-220.
15. C. Y. Yang, S. J. Cai, H. Liu, and C. Pidgeon. Immobilized artificial membranes - screens for drug membrane interactions. Adv. Drug Del. Rev. 23:229-256 (1996).
16. C. Benistant, M. P. Dehouck, J. C. Fruchart, R. Cechelli, and M. Lagarde. Fatty acid composition of brain endothelial cells: effect of co-culture with astrocytes. J. Lipid Res. 36:2311-2319 (1995).
17. S. E. Wright, J. Courtland White, and L. Huang. Partitioning of tenoposide into membranes and the role of lipid composition. Biochim. Biophys. Acta - Biomembr. 1021:105-113 (1990).
18. Q. R. Smith. Methods of study. In M. W. B. Bradbury (ed.), Physiology and Pharmacology of the Blood-Brain Barrier, Springer Verlag, Heidelberg, 1992, pp. 23-52.
19. C. Hansch and A. Leo. Substituent constants for correlation analysis in chemistry and biology. Wiley and Sons, New York, pp. 169-330 (1979).
20. W. M. Pardridge and L. J. Mietus. Transport of steroid hormones through the rat blood-brain barrier. J. Clin Invest. 64:145-154 (1979).
21. E. M. Cornford, L. D. Braun, W. H. Oldendorf, and M. A. Hill. Comparison of lipid-mediated blood-brain barrier penetrability in neonates and adults. Cell. Physiol. 12:C161-C168 (1982).
22. S. D. Kramer and H. Wunderli-Allenspach. The pH-dependence in the partitioning behaviour of (RS)-[3H|-propranolol between MDCK cell lipid vesicles and buffer. Pharm. Res. 13:1851-1855 (1996).
23. R. Kaliszan, A. Nasal, and A. Bucinski. Chromatographic hydrophobicity parameter determined on an immobilized artificial membrane column: relationships to standard measures of hydrophobicity and bioactivity. Eur J. Med. Chem. 29:163-170 (1994).
24. M. H. Abraham, H. S. Chadha, R. A. E. Leitao, R. C. Mitchell, W. J. Lambert, R Kaliszan, A. Nasal, and P. Habor. Determination of solute lipophilicity, as log P(octanol) and log P(alkane) using poly(styrene-divinylbenzene) and immobilized artificial membrane stationary phases in reversed-phase high-performance liquid chromatography. J. Chrom. A 766:35-47 (1997).
25. A. Reichel, A. Aleshaiker, D. J. Begley, and N. J. Abbott. In vitro screening for drugs interacting with P-glycoprotein-mediated drug efflux using immortalised rat brain endothelial cells (RBE4). J. Physiol. 491:36P (1996).
26. A. Reichel, D. J. Begley, and N. J. Abbott. Structural requirements of phenylglycine derivatives for affinity to the L-syslem transporter at the blood-brain barrier. J. Physiol. 501:30P-31P (1997).